Mayde some of you can help me.
We are going to develop solid dosage form with immediate release (hard gelatine capsule).
We have to use Apparatus 3 for routine Dissolution (to overcome problem with crosslinking of gelatine) and also for in vitro study.
Has anyone had the same experience?
What documents are regulating the current requirements?